Intracoronary autologous CD34+ stem cell therapy for intractable angina.
about
Stem cell therapy for chronic ischaemic heart disease and congestive heart failureConcise review: therapeutic potential of adipose tissue-derived angiogenic cellsStem cell therapy for chronic ischaemic heart disease and congestive heart failure.Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis.Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis.Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.Decreased levels of circulating CD34(+) cells are associated with coronary heart disease in Japanese patients with type 2 diabetes.Levels and values of circulating endothelial progenitor cells, soluble angiogenic factors, and mononuclear cell apoptosis in liver cirrhosis patients.Concise Review: Endothelial Progenitor Cells in Regenerative Medicine: Applications and ChallengesAdult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review.Stem cell transplantation in cardiovascular disease: an update.Treatment of refractory angina in patients not suitable for revascularization.The Clinical Status of Stem Cell Therapy for Ischemic CardiomyopathyMelatonin enhances survival and preserves functional integrity of stem cells: A review.Can endothelial progenitor cells treat patients with refractory angina?Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials.Cell Therapy for Refractory Angina: A Reappraisal.Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease.Correlation between Therapeutic Efficacy of CD34+ Cell Treatment and Directed In Vivo Angiogenesis in Patients with End-Stage Diffuse Coronary Artery Disease.New Advances in the Management of Refractory Angina Pectoris
P2860
Q24194988-AFC88107-CB9A-463E-A826-034A6AF8B47EQ26998587-909301A0-EB5C-40AA-94D4-06E626442895Q30239945-562319F7-5F39-4713-BD19-0325F73F6CC5Q30729604-B6275DFD-DE2F-466A-84CB-E988DC58B30BQ34804229-52E30A5C-BB58-494F-B5EB-950B6523E767Q35174462-7F3C836F-9A48-4E44-991C-59CD556A12B0Q35879342-C3E582C2-2BA2-43A3-BF35-FAE8F36B6010Q36150527-8E3E0EA3-D801-48BD-AFD7-DA3CDD013784Q36703043-7EE0012F-932C-4F73-B61E-234D4832C7A3Q37698929-2110DE8E-27E4-4F4D-9280-EF47ABABE99CQ38035958-C80EE161-7B72-4DE4-8752-367A54937AC0Q38173640-A6A43960-FE9B-49C1-822E-01D45295762CQ38535126-57178E91-C6C8-4B1D-925D-30228155188AQ38979530-EBEF509F-C5E4-4A12-94D6-486D2A7A250DQ43092460-274E644D-BB65-4A12-BCDA-63F74C7CBA7BQ47190217-8BE67FFB-315D-424E-A2A8-19A9F4BF4D6FQ48155875-52018310-4D36-46BB-B241-55C58E461553Q49288386-977BE648-431D-4F83-9631-C9A1E4023D5EQ53859054-96CB95CA-3F0C-4E1B-AC10-B9C1EC21622CQ57495833-78C82BE1-BB62-4E64-BEEE-BAF862F8C8AA
P2860
Intracoronary autologous CD34+ stem cell therapy for intractable angina.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Intracoronary autologous CD34+ stem cell therapy for intractable angina.
@en
Intracoronary autologous CD34+ stem cell therapy for intractable angina.
@nl
type
label
Intracoronary autologous CD34+ stem cell therapy for intractable angina.
@en
Intracoronary autologous CD34+ stem cell therapy for intractable angina.
@nl
prefLabel
Intracoronary autologous CD34+ stem cell therapy for intractable angina.
@en
Intracoronary autologous CD34+ stem cell therapy for intractable angina.
@nl
P2093
P356
P1433
P1476
Intracoronary autologous CD34+ stem cell therapy for intractable angina.
@en
P2093
P304
P356
10.1159/000320217
P407
P577
2010-10-23T00:00:00Z